Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in HCV Genotype 2 or 3.
Shiffman, Mitchell L.; Suter, Fredy; Bacon, Bruce R.; Nelson, David; Harley, Hugh; Solá, Ricard; Shafran, Stephen D.; Barange, Karl; Lin, Amy; Soman, Ash; Zeuzem, Stefan; New England Journal of Medicine, 2007, vol. 357, issue 2, p 124, ISSN 00284793. ISBN 00284793.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef